MALDI-7090: a new MALDI TOF-TOF Mass Spectrometer combining high throughput, high resolution & high-energy MALDI tandem MS.

Shimadzu introduces the new MALDI-7090TM MALDI TOF-TOF Mass Spectrometer targeted for proteomics and tissue imaging research. The combination of Shimadzu’s extensive MALDI-TOF-TOF expertise with novel patented technology provides the MALDI-7090 with ultimate capabilities for identification and structural characterisation of biomolecules.

Innovative technology incorporated into the MALDI-7090 such as ASDFTM- Axial Spatial Distribution Focussing, delivers market leading high resolution MALDI MS/MS for accurate compound characterisation. This, in combination with proprietary solid state laser technology , true 2 kHz acquisition speed in all modes (MS and MS/MS) , an integrated 10-plate loader and newly designed MALDI SolutionsTM software, sets a new benchmark in MALDI TOF-TOF design.

Assistant professor Takeshi Kawamura from RCAST, University of Tokyo commented “The 2kHz laser speed and high MS/MS resolution in the MALDI-7090 has accelerated our research in proteomics analysis for protein complex and histone modification using LC-MALDI”

Furthermore, the 20keV high energy CID capability of the MALDI-7090 efficiently produces additional fragment ions to further enhance characterisation. When commenting on the value of high-energy CID and high resolution MS/MS capabilities of the MALDI-7090, Professor Guenter Allmaier from the Technical University of Vienna said “High-energy CID is the only way to locate double bonds in compounds containing fatty acids without any derivatization - e.g. of triglycerides in plant oils used as food or corcins (color responsible structures) isolated in saffron . Data interpretation for structure elucidation of such high-energy CID spectra without isotopic resolved fragment ions is very hard to achieve.”

Comprising a powerful range of tools for method development, acquisition, data processing and interpretation, MALDI Solutions software allows automatic and manual control of the MALDI-7090 and has been designed to provide a flexible platform in the hands of both novice and expert users. Targeted software modules within MALDI Solutions address a wide variety of research applications such as proteomics and tissue imaging amongst others.

Commenting on the launch of the MALDI-7090 Mr Kozo Shimazu, Managing director of Kratos Analytical wholly owned subsidiary of Shimadzu Corporation, stated “We are very proud to announce the release of the MALDI-7090 at ASMS 2013. This newly designed MALDI TOF-TOF Mass Spectrometer broadens the Shimadzu MALDI product portfolio into the high performance high-throughput research field. The MALDI-7090 is the perfect complement to our AXIMA range of MALDI TOF and MALDI-QIT TOF instruments which already provide MS, MS/MS and MSn capabilities. The MALDI-7090 offers ultimate sample throughput with high energy CID and high resolution MS/MS. This introduction forms an integral part of Shimadzu’s comprehensive mass spectrometry range of LCMS, GCMS and MALDI TOF Mass Spectrometers.


 

For further information please contact Lorna Basbas at info@shimadzu.com.au

For more product information visit MALDI-7090TM MALDI TOF-TOF Mass Spectrometer

 

Type: 
News

NEWS / EVENT

For Research Use Only. Not for use in diagnostic procedures.

This page may contain references to products that are not available in your country. Please contact us to check the availability of these products in your country.